Skip to main content
Equibles

China Universal Asset Management Co., Ltd.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1906594 SHANGHAI, F4
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$546,352
+$546,352 QoQ
Shares Held
6,368
-11.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 70 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $13,307,210 across 13 Diagnostics & Research names. ADPT ranks #8 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 21,103 $3,166,083
2 MEDP
Medpace Holdings, Inc.
 4,545 $2,406,986
3 TMO
Thermo Fisher Scientific Inc.
 4,000 $2,005,440
4 IDXX
Idexx Laboratories Inc /De
 2,735 $1,439,813
5 NTRA
Natera, Inc.
 3,600 $977,220
6 VCYT
Veracyte, Inc.
 12,699 $745,812
7 GRAL
GRAIL, Inc.
 9,330 $636,959
8 ADPT
Adaptive Biotechnologies Corp
This page 		6,368 $546,352

All Filings in ADPT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $546,352 25,471
2026-03-31 — 28,925
2025-12-31 — 26,477
2025-09-30 — 30,291
2025-06-30 — 30,512
2025-03-31 — 29,602
2024-12-31 — 31,292
2024-09-30 — 28,364
2024-06-30 — 17,314
2024-03-31 — 27,896
2023-12-31 — 16,747
2023-09-30 — 3,719
2023-06-30 — 1,891
2023-03-31 — 1,940
2022-12-31 — 1,453
2022-09-30 — 1,338